In conclusion, the fines to be imposed, pursuant to Article 15(2)(a) of Regulation No 17, should be as follows:
–
Rhône-Poulenc Biochimie SA/Aventis Pharma SA: EUR 2,85 million
–
Merck KgaA: EUR 0 million.
In conclusion, the fines to be imposed, pursuant to Article 15(2)(a) of Regulation No 17, should be as follows:
Rhône-Poulenc Biochimie SA/Aventis Pharma SA: EUR 2,85 million
Merck KgaA: EUR 0 million.